Navigation Links
Ellman International Announces Executive Team Hire
Date:9/1/2010

OCEANSIDE, N.Y., Sept. 1 /PRNewswire/ -- Ellman International, Inc., a New York based developer, manufacturer and marketer of RF devices for surgical and aesthetic procedures, announced that Frank D. D'Amelio will join its executive team in the position of Chief Operating Officer (COO), Executive Vice President. "We are proud to welcome Mr. D'Amelio, a senior medical device professional who will help guide the company's continued growth," said Chief Executive Officer Rick Epstein.

Innovation and aggressive new product development will mark the next phase for Pelleve and Ellman International.  "Frank's extensive experience in developing strong global strategic alliances will be invaluable as we seek new breakthrough technologies to reinforce our versatility in surgical and non-surgical aesthetic systems," said Mr. Epstein.

D'Amelio brings over 25 years of executive experience in the areas of worldwide business development, manufacturing and operations, and the strategic research and development portfolio management.  Most recently, he served as the President of LTC Technologies, a bipolar tissue sealing and welding company and was the former Chief Technology Officer of Gyrus/ACMI, a leading global medical visualization and surgical energy company. At Gyrus/ACMI, Mr. D'Amelio developed and launched numerous endoscopic and electrosurgical systems for the GI, general surgery, urology and gynecology markets and formed a number of significant strategic alliances with other medical device companies.  He is a named inventor of approximately 40 worldwide issued or pending patents.

"As we plan for continued growth, we need strong, globally experienced medical device leaders. Frank will complement our already diverse & dynamic sales and marketing leadership teams," added Epstein.

"Ellman International and Pelleve are well positioned and offer a great platform for both internal development of new leading edge products and properly structured strategic alliances.  I look forward to working with the marketing, sales and financial teams at Ellman to bring these products and services to the market," said D'Amelio.

For more information, visit www.ellman.com and www.pelleve.com.

About Ellman International

Established in 1959, Ellman International (Oceanside, New York) is a privately held developer, manufacturer and marketer of medical devices for surgical procedures requiring cutting, coagulating, and tissue ablation. A trusted leader in high frequency radiowave energy sources, Ellman's advanced technologies offer unique versatility and precision to the surgical and aesthetic markets. In 2008, Baird Capital Partners and an investment group, which includes Ellman's senior executives, acquired Ellman.  

The company's proven product platform includes the Surgitron® Dual RF™ S5, which provides patented 4.0 MHz energy delivery for maximum control in precision cutting, with more versatility than other technologies in the office and clinic environments. The Dual RF™ S5 also powers the Pelleve™ Wrinkle Reduction System, the innovative, FDA-cleared skin tightening system for nonablative wrinkle treatment. Pelleve™ safely treats facial wrinkles without surgery by improving skin firmness for a naturally refreshed appearance. For more information, please visit www.ellman.com and www.pelleve.com.


'/>"/>
SOURCE Ellman International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Yongye International Announces RMB 400 Million Revolving Credit Facilities
2. Yongye International to Present at 2010 ROTH Fall Conference
3. Yongye International Announces Opening of New Production Facility
4. Award-Winning U.S. Talk Show Host Montel Williams Joins Rex Bionics New International Advisory Board
5. PRA International to Exhibit at ESCs Annual Conference
6. International Research Team Closes In On Cause of Common Form of Muscular Dystrophy
7. OXIS International, Inc. Announces Publication of Positive Results of Ergothioneine Safety Study in the Journal TOXICOLOGY
8. Boston Scientifics Womens Health Products Featured in Studies at the Joint Annual Meeting of the International Continence Society and International Urogynecological Association
9. China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010
10. PRA International Hosts Audio Conference on CV Drug Development
11. Dyadic International Reports 2010 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):